WO2011116663A1 - 2',2-双噻唑非核苷类化合物及其制备方法、药物组合物和作为肝炎病毒抑制剂的用途 - Google Patents
2',2-双噻唑非核苷类化合物及其制备方法、药物组合物和作为肝炎病毒抑制剂的用途 Download PDFInfo
- Publication number
- WO2011116663A1 WO2011116663A1 PCT/CN2011/071851 CN2011071851W WO2011116663A1 WO 2011116663 A1 WO2011116663 A1 WO 2011116663A1 CN 2011071851 W CN2011071851 W CN 2011071851W WO 2011116663 A1 WO2011116663 A1 WO 2011116663A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bisthiazole
- hepatitis
- group
- substituted
- nucleoside compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Definitions
- Still another object of the present invention is to provide a drug for hepatitis B and/or hepatitis C virus inhibitors.
- a composition comprising the 2',2-bisthiazole non-nucleoside compound of the present invention as an active ingredient.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013500316A JP5777696B2 (ja) | 2010-03-24 | 2011-03-16 | 2’,2−ビスチアゾール非ヌクレオシド系化合物及びその調製方法、医薬組成物、及び抗肝炎ウイルス阻害剤としての用途 |
KR1020127027636A KR101472944B1 (ko) | 2010-03-24 | 2011-03-16 | 2',2-비스티아졸 비뉴클레오시드 화합물, 이의 제조방법, 이를 포함하는 약학 조성물 및 이의 간염 바이러스 억제제로서의 용도 |
EP11758773.3A EP2551266A4 (en) | 2010-03-24 | 2011-03-16 | NON-NUCLEOSIDE 2 ', 2-DITHIAZOLE COMPOUNDS, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND USES AS HEPATITIS VIRUS INHIBITORS |
SG2012077939A SG184955A1 (en) | 2010-03-24 | 2011-03-16 | 2',2-bisthiazole non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof |
US13/636,488 US8426606B2 (en) | 2010-03-24 | 2011-03-16 | 2′,2-bisthiazole non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010131636.1 | 2010-03-24 | ||
CN201010131636.1A CN102199133B (zh) | 2010-03-24 | 2010-03-24 | 2’,2-双噻唑非核苷类化合物及其制备方法、药物组合物和作为肝炎病毒抑制剂的用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011116663A1 true WO2011116663A1 (zh) | 2011-09-29 |
Family
ID=44660153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2011/071851 WO2011116663A1 (zh) | 2010-03-24 | 2011-03-16 | 2',2-双噻唑非核苷类化合物及其制备方法、药物组合物和作为肝炎病毒抑制剂的用途 |
Country Status (7)
Country | Link |
---|---|
US (1) | US8426606B2 (zh) |
EP (1) | EP2551266A4 (zh) |
JP (1) | JP5777696B2 (zh) |
KR (1) | KR101472944B1 (zh) |
CN (1) | CN102199133B (zh) |
SG (1) | SG184955A1 (zh) |
WO (1) | WO2011116663A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2746256A1 (en) | 2012-12-19 | 2014-06-25 | Basf Se | Fungicidal imidazolyl and triazolyl compounds |
WO2014095249A1 (en) | 2012-12-19 | 2014-06-26 | Basf Se | Fungicidal imidazolyl and triazolyl compounds |
US9643941B2 (en) | 2014-04-04 | 2017-05-09 | Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | 2,2′-tandem dithiazole compound, preparation method therefor, and use thereof |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104030959B (zh) * | 2014-06-24 | 2016-08-24 | 苏州东南药业股份有限公司 | 一种氘代的丙型肝炎病毒抑制剂 |
CN105503730B (zh) * | 2015-12-25 | 2018-06-22 | 山东大学 | 吡唑类衍生物及其制备方法与应用 |
CN107793375A (zh) * | 2016-08-31 | 2018-03-13 | 中国科学院上海药物研究所 | 一类芳基2,2’‑串联双噻唑类化合物及其制备方法和用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007147336A1 (en) | 2006-06-13 | 2007-12-27 | Shanghai Institue Of Materia Medica, Chinese Academy Of Sciences | Heterocyclic non-nucleoside compounds, their peparation, pharmaceutical composition and their use as antiviral agents |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1834095B (zh) * | 2005-03-18 | 2011-04-20 | 中国科学院上海药物研究所 | 一类非核苷类抗病毒抑制剂及其制备方法和用途 |
CN101626683B (zh) * | 2006-12-28 | 2015-08-19 | 埃迪尼克斯医药公司 | 用于治疗病毒感染的化合物和药物组合物 |
-
2010
- 2010-03-24 CN CN201010131636.1A patent/CN102199133B/zh not_active Expired - Fee Related
-
2011
- 2011-03-16 US US13/636,488 patent/US8426606B2/en not_active Expired - Fee Related
- 2011-03-16 EP EP11758773.3A patent/EP2551266A4/en not_active Withdrawn
- 2011-03-16 JP JP2013500316A patent/JP5777696B2/ja not_active Expired - Fee Related
- 2011-03-16 WO PCT/CN2011/071851 patent/WO2011116663A1/zh active Application Filing
- 2011-03-16 KR KR1020127027636A patent/KR101472944B1/ko not_active IP Right Cessation
- 2011-03-16 SG SG2012077939A patent/SG184955A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007147336A1 (en) | 2006-06-13 | 2007-12-27 | Shanghai Institue Of Materia Medica, Chinese Academy Of Sciences | Heterocyclic non-nucleoside compounds, their peparation, pharmaceutical composition and their use as antiviral agents |
CN101443330A (zh) * | 2006-06-13 | 2009-05-27 | 中国科学院上海药物研究所 | 杂环非核苷类化合物及其制备方法、药物组合物和作为抗病毒抑制剂的用途 |
Non-Patent Citations (1)
Title |
---|
See also references of EP2551266A4 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2746256A1 (en) | 2012-12-19 | 2014-06-25 | Basf Se | Fungicidal imidazolyl and triazolyl compounds |
WO2014095249A1 (en) | 2012-12-19 | 2014-06-26 | Basf Se | Fungicidal imidazolyl and triazolyl compounds |
US9643941B2 (en) | 2014-04-04 | 2017-05-09 | Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | 2,2′-tandem dithiazole compound, preparation method therefor, and use thereof |
KR101748229B1 (ko) | 2014-04-04 | 2017-06-16 | 상하이 인스티튜트 오브 마테리아 메디카 차이니즈 아카데미 오브 싸이언시즈 | 2,2'-비스-티아졸계 화합물 및 그 제조방법과 용도 |
Also Published As
Publication number | Publication date |
---|---|
CN102199133A (zh) | 2011-09-28 |
JP5777696B2 (ja) | 2015-09-09 |
US8426606B2 (en) | 2013-04-23 |
EP2551266A1 (en) | 2013-01-30 |
KR101472944B1 (ko) | 2014-12-16 |
JP2013522328A (ja) | 2013-06-13 |
EP2551266A8 (en) | 2013-05-29 |
CN102199133B (zh) | 2015-08-19 |
US20130059895A1 (en) | 2013-03-07 |
KR20120139836A (ko) | 2012-12-27 |
EP2551266A4 (en) | 2013-08-14 |
SG184955A1 (en) | 2012-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6506836B2 (ja) | B型肝炎ウイルス感染症の処置および予防のための新規ピリダゾンおよびトリアジノン | |
CN109641868B (zh) | 流感病毒复制抑制剂及其使用方法和用途 | |
JP7079527B2 (ja) | 環内チアミジノアミド-アリールアミド系化合物及びb型肝炎を治療するためのその用途 | |
JP5974124B2 (ja) | キナーゼ阻害剤の組成物ならびに癌およびキナーゼに関連する他の疾患の治療のためのそれらの使用 | |
JP6704416B2 (ja) | インフルエンザウイルスの複製の阻害剤を調製する方法 | |
JP7123429B2 (ja) | 二環式縮合環系ヌクレオカプシド阻害剤および薬物としてb型肝炎を治療するためのその使用 | |
CN102448952B (zh) | 抗病毒化合物和其用途 | |
Jia et al. | Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors | |
WO2011116663A1 (zh) | 2',2-双噻唑非核苷类化合物及其制备方法、药物组合物和作为肝炎病毒抑制剂的用途 | |
CN104718213A (zh) | 5,5-杂芳族抗感染化合物 | |
JP2014515730A (ja) | キナーゼ阻害剤としてのアミノキノリン | |
WO2011127833A1 (zh) | 苯并杂环类化合物及其制备方法和用途 | |
JP2010535155A (ja) | ウイルスポリメラーゼ阻害剤 | |
CN102584690A (zh) | 吡啶-2-酮类化合物,其制备方法以及所述吡啶-2-酮类化合物的应用 | |
JP6857617B2 (ja) | インフルエンザウイルスの複製の阻害剤 | |
WO2020221006A1 (zh) | 一种bet蛋白抑制剂、其制备方法及用途 | |
EP1490350B1 (en) | Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase | |
JP2022517984A (ja) | 環内チアミジノアミド-アリールアミド系化合物及びb型肝炎を治療するためのその使用 | |
KR101919642B1 (ko) | 피페라진 유도체, 이를 제조하는 방법, 및 인슐린 저항성의 치료에서 이의 용도 | |
CN106810553B (zh) | 3-(4,5-取代氨基嘧啶)苯基衍生物及其应用 | |
WO2023091550A1 (en) | Methods of treating estrogen receptor-associated diseases | |
JPH04356466A (ja) | 新規キノリン誘導体及びそれを有効成分として含有する制癌剤効果増強剤 | |
CN113045589A (zh) | 流感病毒复制抑制剂及其用途 | |
CN115197164A (zh) | 新型噻唑类化合物及其制备方法和用途 | |
TW201116522A (en) | 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of Hepatitis C NS5B polymerase, the pharmaceutical composition thereof and their therapeutic use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11758773 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013500316 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 8867/CHENP/2012 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 20127027636 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011758773 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13636488 Country of ref document: US |